Deep vein thrombosis or DVT affects more than 1 million Indians every year, and its complications such as pulmonary embolism, loose clot migration to the lungs, etc., can be life-threatening. This clotting of small and large blood vessels has been on the rise since the appearance of the thrombogenic Covid-19 virus. DVT, a type of vein cancer, slowly but surely affects blood flow and has the potential to cause persistent pain and ulcers in the legs, leading to a severe deterioration in a person’s quality of life .
DVT is the formation of blood clots in the veins of our body, usually the calf and thigh veins. Because these calf veins eventually move to the heart and lungs, a clot in these veins can easily loosen and migrate to these vital structures, blocking blood flow to the lungs, causing a pulmonary embolism-like condition. Life-threatening complications may occur.
Symptoms of DVT are swelling in the legs, cramping pain, change in skin color and a feeling of warmth in the affected leg. Warning signs can be sudden shortness of breath, dizziness, fainting, palpitations, coughing up blood and severe swelling of the legs, where one needs to be taken to a hospital immediately.
Although the disease is serious, the solution is quite simple. Treatment of DVT is a preliminary procedure of thrombolysis to remove the clot. With the advancement of medical technology and expertise, most procedures today can be performed by a small puncture without any surgery. To prevent loose clots from traveling to the lungs, a special inferior vena cava (IVC) filter is inserted into the main vein of the abdomen.
To discuss this important issue, the event Endovascular Live i.e. EVL 6.0 has been organized in New Delhi. EVL is a global platform comprising 13 national and international centers with over 350 vascular specialists from major cities across India, including Tier-II and Tier-III countries, Nepal, Bangladesh and West Asian countries. Live cases are meant for interpersonal learning through demonstrations. Being performed by highly skilled Endovascular experts.
This time, the 3-day EVL Thursday began with the topic of clot management – how to treat venous clots (DVT) and how to clot (embolise) a bleeding blood vessel.
Dr VS Bedi, Chairman, Department of Vascular Surgery at Sir Ganga Ram Hospital and Organizing Committee of EVL, spoke about how clot management is an important issue in today’s fast-growing post-pandemic world.
These blood vessels require a process of embolization via micro-puncture and clot formation using special materials such as gelatin/PVA particles/sclerosants, and coils, thus avoiding major surgery.
This way of blood flow to the cancerous mass not only accelerates healing, but also makes some stubborn cancers curable, bringing new hope to those suffering from the dreaded disease.
This highly sophisticated treatment requires immense skills which were not easily available a few years back except in a few centers of excellence in major metro cities. Over the years, EVL has demonstrated many different types of thrombosis and embolization, contributing to the advancement of the skills of endovascular specialists, valued through sophisticated discussion on each step of the procedure and by the legends of endovascular interventions. Share the insights into which TERN has ensured that such advanced treatments are available in Tier-2 and Tier-3 cities by training interventionists across India.
Asked if this dangerous clot is a man’s nemesis, Dr Ajay Yadav smiled and replied: “Clotting in normal blood vessels is a problem, but abnormal blood vessels really require clotting as a form of treatment. It is a necessary devil.”
These abnormal blood vessels can be an underlying cause of a small bump on the forehead to a large tumor in one’s abdomen. Malformed blood vessels in the uterus are prone to pregnancy loss and heavy bleeding.
With a specialized fellow course in the EVL program, young vascular surgeons observe and experience veterans of the field, which has led to a highly skilled and confident young crop of endovascular specialists.